遗传性出血端膜切除症:从信号洞察到治疗进展
Tala Al Tabosh1, Mohammad Al Tarrass1, Laura Tourvieilhe2
1Biosanté Unit U1292, Grenoble Alpes University, INSERM, CEA, Grenoble, France.
The Journal of clinical investigation
|February 15, 2024
概括
遗传性出血端膜炎症 (HHT) 是一种遗传性血管疾病,由BMP9-10/ENG/ALK1/SMAD4通路的突变引起. 目前的治疗方法看起来很有前途,但对于这种出血障碍,没有FDA批准的治疗方法.
科学领域:
- 血管生物学 血管生物学
- 遗传学 是一个遗传学.
- 医学研究 医学研究
背景情况:
- 遗传性出血性电脉切开症 (HHT) 是一种遗传性血管疾病,每5000人中就有1人受到影响.
- 在肺,肝脏和大脑中表现为粘膜皮肤端膜切除和内脏动脉静脉形 (AVM).
- 由BMP9-10/ENG/ALK1/SMAD4信号通路中的功能丧失突变引起的.
研究的目的:
- 审查当前对HHT突变信号通路的见解.
- 探索HHT途径和亲血管性途径之间的交叉,特别是VEGF.
- 讨论用于HHT治疗的药物的重新用途.
主要方法:
- 关于HTH病原和治疗的当前文献的综述.
- 分析涉及HHT的信号通路,包括BMP9-10/ENG/ALK1/SMAD4和VEGF.
- 评估新兴的治疗策略和药物重新用途.
主要成果:
- BMP9-10/ENG/ALK1/SMAD4通路是HT病原发生的核心.
- 与VEGF途径的交叉提供治疗目标.
- 重用药物在减轻HHT症状严重程度方面显示出好处.
结论:
- 了解HHT中的分子通路对于开发有效治疗方法至关重要.
- 针对信号通路之间的交叉通话为HTH治疗提供了一个有前途的途径.
- 尽管治疗方面取得了进展,但HHT仍然是一个没有FDA或EMA批准的治疗方法的疾病.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Mechanism of Angiogenesis
5.5K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Esophageal Varices-II: Clinical Features and Management
67
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
67


